Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ELUTIA INC. | 118,750 | reported | 30 Jan 2026 | tx 6+228,166−6,250 |
| GUIDANT CORP | 89,079 | reported | 01 Nov 2005 | tx 11+193,616−123,666 |
| Axogen, Inc. | 86,743 | reported | 09 Jun 2025 | tx 39+316,521−1,261,645 |
| BIOPURE CORP | 85,600 | reported | 15 Sept 2008 | tx 9+164,000−5,000 |
| ENDOLOGIX INC /DE/ | 43,200 | reported | 03 Apr 2019 | tx 14+323,429 |
| Bioventus Inc. | 32,282 | reported | 03 Jun 2025 | tx 16+202,764−85,241 |
| LEMAITRE VASCULAR INC | 2,805 | reported | 22 Dec 2006 | tx 1+2,805 |
| ENTELLUS MEDICAL INC | 0 | reported | 28 Feb 2018 | tx 8+32,500−47,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jan 2026 | PURCHASE | ELUTIA INC. | 20,000 | 1.04 USD | |
| 29 Jan 2026 | PURCHASE | ELUTIA INC. | 15,000 | 1.06 USD | |
| 28 Jan 2026 | PURCHASE | ELUTIA INC. | 15,000 | 1.06 USD | first after silence |
| 01 Dec 2025 | EXERCISE | ELUTIA INC. | 6,250 | — | |
| 01 Dec 2025 | EXERCISE | ELUTIA INC. | 6,250 | 0.00 USD | deriv |
| 09 Oct 2025 | GRANT_AWARD | ELUTIA INC. | 171,916 | 0.00 USD | deriv |
| 09 Jun 2025 | SALE | Axogen, Inc. | 4,073 | 10.61 USD | |
| 02 Jun 2025 | EXERCISE | Bioventus Inc. | 26,493 | 0.00 USD | |
| 02 Jun 2025 | EXERCISE | Bioventus Inc. | 26,493 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | Bioventus Inc. | 32,282 | 0.00 USD | deriv |
| 01 Sept 2024 | EXERCISE | Axogen, Inc. | 11,904 | 0.00 USD | |
| 01 Sept 2024 | EXERCISE | Axogen, Inc. | 11,904 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | Bioventus Inc. | 26,493 | 0.00 USD | deriv |
| 07 Jun 2024 | EXERCISE | Bioventus Inc. | 30,400 | 0.00 USD | |
| 07 Jun 2024 | EXERCISE | Bioventus Inc. | 30,400 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Axogen, Inc. | 10,653 | — | |
| 06 Jun 2024 | GRANT_AWARD | Axogen, Inc. | 18,248 | 0.00 USD | deriv |
| 01 Sept 2023 | GRANT_AWARD | Axogen, Inc. | 20,436 | 0.00 USD | deriv |
| 01 Sept 2023 | GRANT_AWARD | Axogen, Inc. | 11,904 | 0.00 USD | deriv |
| 16 Aug 2023 | PURCHASE | Axogen, Inc. | 10,000 | 6.11 USD | first after silence |
| 06 Jun 2023 | EXERCISE | Bioventus Inc. | 16,648 | 0.00 USD | |
| 06 Jun 2023 | EXERCISE | Bioventus Inc. | 16,648 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Bioventus Inc. | 30,400 | 0.00 USD | deriv |
| 01 Jun 2023 | EXERCISE | Axogen, Inc. | 6,459 | 0.00 USD | |
| 01 Jun 2023 | EXERCISE | Axogen, Inc. | 6,459 | 0.00 USD | deriv |
6 purchases reported after at least 12 months of silence — most recent on 28 Jan 2026.